Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl salicylic acid for positive-margin cervical intraepithelial neoplasia II/III after surgery (Phase II)
2004-003944-23Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of aspirin in cervical intraepithelial neoplasia (CIN), sponsored by Medical University of Vienna. Primary endpoints: Abnormal Pap smears after surgery and Safety and side effects. Started Mar 2005; status: terminated.
02
Drugs
aspirin
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on 2004-003944-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003944-23.